Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Premedication”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,783 records · Page 99Linked to original sources
PubMed1999

Premedical science

Explore the source record for details and available documents.

Journal Article↗
PubMed1980

Intravenous anaesthesia in horses after xylazine premedication.

The effects of combining large doses of xylazine (1.1 mg per kg intravenously) with ketamine, methohexitone and thiopentone were studied in four experimental ponies. Onset of anaesthesia was more delayed after ketamine than after the barbiturates. Assessment of smoothness of induction and recovery indicated that all three combinations were effective and acceptable. Injection of xylazine was followed by atrioventricular (A-V) block which could be prevented by the prior administration of atropine. Blood pressure was well maintained with all three combinations of drugs. Arterial oxygen tension decreased as soon as the ponies became recumbent but there were no marked changes in arterial blood pH or carbon dioxide tension. Cardiac output was measured in one pony and was found to be least affected by ketamine. There was no great difference between the recumbency times after ketamine and methohexitone but thiopentone produced a significantly longer period of recumbency. In every instance the animals stood at the first attempt without struggling or excitement. The ability of the three drug combinations to produce surgically useful anaesthesia was not tested.

Anesthesia, Intravenous↗
PubMed1998

Clinical efficacy and safety of propofol or ketamine anaesthesia in dogs premedicated with medetomidine.

Combinations of medetomidine with either propofol or ketamine were compared for the sedation and induction of anaesthesia in dogs undergoing a variety of surgical (60 per cent) and non-surgical (40 per cent) procedures. Eighty-four dogs were used at four sites. Medetomidine was administered intramuscularly at a dose of 1000 micrograms/m2 body surface area 10 to 15 minutes before the induction of anaesthesia by the administration of propofol (n = 44) or ketamine (n = 40) dosed to effect. The dogs became sedated by medetomidine after a mean (sd) time of 6.7 (5.4) minutes, and their heart rates and respiration rates decreased. Sixteen of the dogs suffered an adverse effect, 13 of them vomited. Anaesthesia was induced by the intravenous administration of propofol (2.1 [0.7] mg/kg) or ketamine (3.7 [1.9] mg/kg), and further doses of the anaesthetic were given, depending on the length of the operation, once in 17 per cent, twice in 11 per cent and three or more times in 24 per cent of the cases. The heart rate of the dogs anaesthetised with ketamine was significantly higher than that of the dogs anaesthetised with propofol, but there were no other significant physiological differences. There were 11 adverse side-effects in the ketamine group compared with five in the propofol group and they were generally more severe. The quality of the recovery from anaesthesia was considered to be smooth in 89 per cent of the propofol group but in only 63 per cent of the ketamine group.

Anesthesia↗
PubMed2002

Thalidomide-induced morbilliform rash: diagnosis and continuation of therapy, premedicated with methylprednisolone.

In the past few years, thalidomide is experiencing a revival in many different fields as a last therapeutic option, because of the potential severe adverse drug reactions (ADR) induced by this drug (teratogenicity, peripheral neuropathy and sedation). Taking into consideration the increased use, we should focus on the prevalence of these and other ADR as well on their management. We describe a patient with multiple myeloma who presented with a morbilliform rash induced by thalidomide. Reintroduction of the drug confirmed the diagnosis. Nevertheless we continued the thalidomide treatment, although combined with methylprednisolone 64 mg. There was no recurrence of the cutaneous drug reaction (CDR). To the best of our knowledge, this is the first case showing that systemic steroids can help to 'treat through' a thalidomide CDR.

Aged↗
PubMed1983

Dose-finding and premedication studies with zopiclone.

The new non-benzodiazepine hypnotic, zopiclone, was investigated as a preanaesthetic medication in a randomized, double-blind, placebo-controlled study in healthy patients scheduled for minor gynaecological surgery. Initially a dose-finding study was conducted in which zopiclone 3.75 mg, 7.5, and 11.25 mg was compared with diazepam 10 mg and placebo; 7.5 mg was established as the optimum dose of zopiclone. In the main study zopiclone 7.5 mg was comparable to diazepam 10 mg at 20, 40, and 60 min after administration and more efficacious at 90 min.

Adult↗
PubMed1992

Increased lipid binding to thrombi in coronary artery disease. Findings in patients without premedication in native (not anticoagulated) test systems.

Thrombi and clots were produced from native (i.e., not anticoagulated) platelet-rich and platelet-poor plasma from patients with coronary artery disease and control subjects who had not taken any medication known to influence plasma lipids, coagulation, or platelet aggregation. The clotting times were recorded, and the lipid content of clots, thrombi, platelets, plasma, and high density lipoprotein was analyzed. Thrombi produced from native platelet-rich plasma were 46% heavier in coronary artery disease patients and contained about 20% more phospholipids and free cholesterol and about twice the amount of triglycerides and esterified cholesterol in both absolute and relative amounts with respect to the corresponding lipids of plasma plus platelets. The elevated content of lipids not only increases the size of the thrombi but also changes their quality because of an increased content in plasmatic lipids, as platelets contain only trace amounts of triglycerides and cholesterol esters. In agreement herewith, fibrinogen and maximal amplitude on the thrombelastogram were increased in coronary artery disease patients, whereas the thrombus-forming time and clotting times of platelet-poor and platelet-rich plasma were shortened, indicating accelerated coagulation and activation of platelets. Analysis of these results suggests a disturbed interrelation in coronary artery disease between lipids and hemostasis, in which platelets, high density lipoprotein, and lipoproteins rich in triglycerides and cholesterol esters may play a role.

Blood Coagulation↗